The clinical information you need, at your fingertips.

An umbrella review suggests potential protective effects beyond cardiometabolic benefits ...

An observational study suggests dysregulation of parasympathetic and sympathetic systems may underlie depressive symptoms in patients who fail standard therapies ...

A new analysis finds those most at risk of losing coverage have greater physical and mental health impairment ...

Kresladi (marnetegragene autotemcel) is the first gene therapy for pediatric patients with this rare, inherited immune deficiency characterized by recurrent, life-threatening infections ...

In a randomized trial, changing from dulaglutide to tirzepatide led to greater improvements in quality of life, physical function, and emotional well-being ...

For patients with established ASCVD, guidelines have increasingly endorsed very low LDL-C goals despite limited randomized evidence directly comparing targets …

With growing adoption of universal mupirocin decolonization in ICUs to reduce MRSA burden, concerns have emerged about whether recent treatment compromises the reliability of MRSA PCR nasal screening …

Postmarketing cases include hospitalizations, rare bile duct injury, and deaths; clinicians urged to monitor closely …

Tozorakimab, an IL-33–targeting biologic, reduced moderate-to-severe exacerbations across broad patient populations in the OBERON and TITANIA trials …